Systemic Chemotherapy Is Modulated by Platelet-Activating Factor-Receptor Agonists
Chemotherapy is used to treat numerous cancers including melanoma. However, its effectiveness in clinical settings is often hampered by various mechanisms. Previous studies have demonstrated that prooxidative stressor-mediated generation of oxidized lipids with platelet-activating factor-receptor (P...
Saved in:
Main Authors: | Ravi P. Sahu (Author), Matheus Ferracini (Author), Jeffrey B. Travers (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clearance of Apoptotic Cells by Macrophages Induces Regulatory Phenotype and Involves Stimulation of CD36 and Platelet-Activating Factor Receptor
by: Matheus Ferracini, et al.
Published: (2013) -
Agonist bias and agonist‐dependent antagonism at corticotrophin releasing factor receptors
by: Zoe Tasma, et al.
Published: (2020) -
Experimental GABA A Receptor Agonists and Allosteric Modulators for the Treatment of Focal Epilepsy
by: Janković SM, et al.
Published: (2021) -
Signaling Pathways of Receptors Involved in Platelet Activation andShedding of These Receptors in Stored Platelets
by: Asra Amelirad, et al.
Published: (2019) -
Sex Differences in Kappa Opioid Receptor Agonist Mediated Attenuation of Chemotherapy-Induced Neuropathic Pain in Mice
by: Kelly F. Paton, et al.
Published: (2022)